Aims: We investigated the mechanism (s) by which valsartan, a selective antagonist of
angiotensin subtype 1 (AT1) receptor, decreased plasma glucose in streptozotocin (STZ) …

Objectives In the present study, we use valsartan, a highly selective antagonist for
angiotensin 1 (AT 1) receptor subtype, to investigate the effect of AT 1 receptor on the …

Aims/hypothesis The present study investigated the effect of agmatine, an endogenous
ligand of imidazoline receptors, on plasma glucose in streptozotocin-induced diabetic rats …

To better understand the insulin-independent plasma glucose–lowering action of metformin,
we used streptozotocin (STZ)-induced diabetic rats to investigate the possible mechanisms …

We investigated the plasma glucose-lowering mechanism (s) of Rh2, a ginsenoside derived
from Panax ginseng, in rats with streptozotocin-induced diabetes (STZ-diabetic rats). After …

The role of α 1A-adrenoceptors in the regulation of opioid secretion from the adrenal glands
of streptozotocin-induced diabetic rats (STZ-diabetic rats) was examined in an attempt to …

Although serotonin, serotonin uptake inhibitors and serotonin precursors (including
tryptophan or 5-hydroxytryptophan) are known to have hypoglycemic action in rodents or …

We investigated the mechanism (s) by which isoferulic acid lowers plasma glucose levels in
streptozotocin-induced diabetic rats (STZ-diabetic rats). In STZ-diabetic rats, isoferulic acid …

Effects of oral administration of the angiotensin II receptor antagonist (selective AT1-
subtype) irbesartan on glucose tolerance and insulin action on skeletal-muscle glucose …

Objective The aims of this study were to assess the renal expression of angiotensin type 1
(AT1) and type 2 (AT2) receptors in diabetic spontaneously hypertensive rats (SHR) and the …